Dong-A Socio Holdings Co., Ltd. (000640.KS)
KRW 110000.0
(4.86%)
KRW 110000.0
(4.86%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1132 Billion KRW | 11.53% |
| 2022 | 1014.86 Billion KRW | 15.07% |
| 2021 | 881.94 Billion KRW | 12.59% |
| 2020 | 783.31 Billion KRW | 1.77% |
| 2019 | 769.68 Billion KRW | 8.84% |
| 2018 | 707.17 Billion KRW | 2.45% |
| 2017 | 690.26 Billion KRW | -4.94% |
| 2016 | 726.16 Billion KRW | 3.04% |
| 2015 | 704.73 Billion KRW | 11.75% |
| 2014 | 630.62 Billion KRW | 10.47% |
| 2013 | 570.87 Billion KRW | -48.38% |
| 2012 | 1105.99 Billion KRW | 4.76% |
| 2011 | 1055.69 Billion KRW | 11.4% |
| 2010 | 947.63 Billion KRW | 9.4% |
| 2009 | 866.23 Billion KRW | 13.44% |
| 2008 | 763.58 Billion KRW | 11.18% |
| 2007 | 686.8 Billion KRW | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 324.49 Billion KRW | 6.42% |
| 2024 Q1 | 304.91 Billion KRW | 0.85% |
| 2023 Q2 | 284.88 Billion KRW | 11.48% |
| 2023 Q1 | 255.54 Billion KRW | -2.14% |
| 2023 Q4 | 302.34 Billion KRW | 4.54% |
| 2023 FY | 1131.86 Billion KRW | 11.53% |
| 2023 Q3 | 289.22 Billion KRW | 1.52% |
| 2022 Q1 | 223.26 Billion KRW | -4.64% |
| 2022 Q2 | 261.04 Billion KRW | 16.92% |
| 2022 Q3 | 269.43 Billion KRW | 3.22% |
| 2022 Q4 | 261.12 Billion KRW | -3.09% |
| 2022 FY | 1014.86 Billion KRW | 15.07% |
| 2021 Q1 | 192.2 Billion KRW | -1.21% |
| 2021 Q2 | 217.22 Billion KRW | 13.01% |
| 2021 Q3 | 238.38 Billion KRW | 9.74% |
| 2021 Q4 | 234.12 Billion KRW | -1.79% |
| 2021 FY | 881.94 Billion KRW | 12.59% |
| 2020 Q2 | 200.3 Billion KRW | 10.59% |
| 2020 FY | 783.31 Billion KRW | 1.77% |
| 2020 Q1 | 181.13 Billion KRW | -1.72% |
| 2020 Q4 | 194.56 Billion KRW | -6.15% |
| 2020 Q3 | 207.3 Billion KRW | 3.5% |
| 2019 Q1 | 166.53 Billion KRW | -5.24% |
| 2019 FY | 769.68 Billion KRW | 8.84% |
| 2019 Q4 | 184.3 Billion KRW | -18.23% |
| 2019 Q3 | 225.4 Billion KRW | 16.52% |
| 2019 Q2 | 193.44 Billion KRW | 16.16% |
| 2018 Q2 | 188.35 Billion KRW | 17.61% |
| 2018 Q1 | 160.15 Billion KRW | -1.32% |
| 2018 FY | 707.17 Billion KRW | 2.45% |
| 2018 Q4 | 175.74 Billion KRW | -3.92% |
| 2018 Q3 | 182.92 Billion KRW | -2.88% |
| 2017 FY | 690.26 Billion KRW | -4.94% |
| 2017 Q4 | 162.28 Billion KRW | -16.28% |
| 2017 Q3 | 193.84 Billion KRW | 6.08% |
| 2017 Q2 | 182.72 Billion KRW | 20.69% |
| 2017 Q1 | 151.4 Billion KRW | -1.81% |
| 2016 Q2 | 235.15 Billion KRW | 40.44% |
| 2016 FY | 726.16 Billion KRW | 3.04% |
| 2016 Q4 | 154.19 Billion KRW | -8.96% |
| 2016 Q1 | 167.44 Billion KRW | -8.29% |
| 2016 Q3 | 169.37 Billion KRW | -27.97% |
| 2015 Q2 | 179.91 Billion KRW | 26.91% |
| 2015 FY | 704.73 Billion KRW | 11.75% |
| 2015 Q1 | 141.76 Billion KRW | -20.66% |
| 2015 Q4 | 182.57 Billion KRW | -8.94% |
| 2015 Q3 | 200.48 Billion KRW | 11.44% |
| 2014 FY | 630.62 Billion KRW | 10.47% |
| 2014 Q3 | 155.68 Billion KRW | 1.18% |
| 2014 Q2 | 153.87 Billion KRW | 8.07% |
| 2014 Q4 | 178.67 Billion KRW | 14.76% |
| 2014 Q1 | 142.38 Billion KRW | -14.23% |
| 2013 Q4 | 166.01 Billion KRW | 16.58% |
| 2013 FY | 570.87 Billion KRW | -48.38% |
| 2013 Q1 | 109.23 Billion KRW | -85.24% |
| 2013 Q2 | 153.21 Billion KRW | 40.27% |
| 2013 Q3 | 142.4 Billion KRW | -7.06% |
| 2012 FY | 1105.99 Billion KRW | 4.76% |
| 2012 Q1 | 218.56 Billion KRW | 0.0% |
| 2012 Q2 | 127.54 Billion KRW | -41.64% |
| 2012 Q3 | 126.4 Billion KRW | -0.9% |
| 2012 Q4 | 740.23 Billion KRW | 485.62% |
| 2011 FY | 1055.69 Billion KRW | 11.4% |
| 2011 Q3 | 241.92 Billion KRW | 7.78% |
| 2011 Q1 | 210.22 Billion KRW | 0.0% |
| 2011 Q2 | 224.45 Billion KRW | 6.77% |
| 2011 Q4 | - KRW | -100.0% |
| 2010 Q3 | 212.1 Billion KRW | -4.18% |
| 2010 FY | 947.63 Billion KRW | 9.4% |
| 2010 Q2 | 221.35 Billion KRW | 10.11% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q1 | 201.03 Billion KRW | 0.0% |
| 2009 Q3 | 208.27 Billion KRW | 2.15% |
| 2009 Q2 | 203.89 Billion KRW | 9.07% |
| 2009 Q1 | 186.94 Billion KRW | 0.0% |
| 2009 FY | 866.23 Billion KRW | 13.44% |
| 2009 Q4 | - KRW | -100.0% |
| 2008 FY | 763.58 Billion KRW | 11.18% |
| 2008 Q3 | 187.48 Billion KRW | 7.58% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 Q1 | 155.59 Billion KRW | 0.0% |
| 2008 Q2 | 174.28 Billion KRW | 12.01% |
| 2007 Q1 | 149.42 Billion KRW | 0.0% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 FY | 686.8 Billion KRW | 0.0% |
| 2007 Q2 | 156.38 Billion KRW | 4.66% |
| 2007 Q3 | 166.13 Billion KRW | 6.23% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 137.2 Billion KRW | -725.017% |
| Ildong Holdings Co., Ltd. | 638.44 Billion KRW | -77.306% |
| HANDOK Inc. | 522.74 Billion KRW | -116.551% |
| Kukje Pharma Co., Ltd. | 135.37 Billion KRW | -736.212% |
| Yuhan Corporation | 1858.98 Billion KRW | 39.106% |
| Dong-A ST Co., Ltd. | 663.98 Billion KRW | -70.487% |
| SAMSUNG PHARM. Co., LTD. | 51.95 Billion KRW | -2078.812% |
| Hanmi Pharm. Co., Ltd. | 1490.88 Billion KRW | 24.072% |
| Hanall Biopharma Co.,Ltd | 134.9 Billion KRW | -739.081% |
| Ilyang Pharmaceutical Co.,Ltd | 370.53 Billion KRW | -205.503% |
| Dong Sung Bio Pharm.Co.,Ltd. | 88.59 Billion KRW | -1177.748% |
| MYUNGMOON Pharm co.,Ltd | 169.56 Billion KRW | -567.583% |
| Hana Pharm Co., Ltd. | 224.45 Billion KRW | -404.33% |
| Yuyu Pharma, Inc. | 137.2 Billion KRW | -725.017% |
| Ilsung Pharmaceuticals Co., Ltd. | 78.05 Billion KRW | -1350.296% |
| REYON Pharmaceutical Co., Ltd. | 151.07 Billion KRW | -649.318% |
| Aprogen pharmaceuticals,Inc. | 87.36 Billion KRW | -1195.737% |
| JW Holdings Corporation | 928.07 Billion KRW | -21.974% |
| Ildong Pharmaceutical Co., Ltd. | 600.75 Billion KRW | -88.429% |
| Chong Kun Dang Pharmaceutical Corp. | 1669.4 Billion KRW | 32.191% |
| JW Pharmaceutical Corporation | 748.52 Billion KRW | -51.231% |
| Shin Poong Pharm.Co.,Ltd. | 200.22 Billion KRW | -465.355% |
| Hyundai Pharmaceutical Co., Ltd. | 180.76 Billion KRW | -526.237% |
| Samil Pharmaceutical Co.,Ltd | 196.34 Billion KRW | -476.535% |
| Jeil Pharmaceutical Co.,Ltd | 726.39 Billion KRW | -55.839% |
| Yuyu Pharma, Inc. | 137.2 Billion KRW | -725.017% |
| Kwang Dong Pharmaceutical Co., Ltd. | 1514.45 Billion KRW | 25.253% |
| Daewoong pharmaceutical Co.,Ltd | 1375.32 Billion KRW | 17.692% |
| JW Pharmaceutical Corporation | 748.52 Billion KRW | -51.231% |
| Yuhan Corporation | 1858.98 Billion KRW | 39.106% |
| Jeil Pharma Holdings Inc | 794.71 Billion KRW | -42.442% |
| Yungjin Pharm. Co., Ltd. | 234.9 Billion KRW | -381.903% |
| Suheung Co., Ltd. | 594.56 Billion KRW | -90.391% |
| JW Pharmaceutical Corporation | 748.52 Billion KRW | -51.231% |
| Samjin Pharmaceuticals Co., Ltd. | 292.12 Billion KRW | -287.502% |
| Korea United Pharm Inc. | 278.94 Billion KRW | -305.818% |
| CKD Bio Corp. | 160.35 Billion KRW | -605.945% |
| Daewon Pharmaceutical Co., Ltd. | 526.95 Billion KRW | -114.821% |
| Dongwha Pharm.Co.,Ltd | 361.1 Billion KRW | -213.48% |
| Whan In Pharm Co.,Ltd. | 230.39 Billion KRW | -391.334% |
| Shin Poong Pharm.Co.,Ltd. | 200.22 Billion KRW | -465.355% |
| Chong Kun Dang Holdings Corp. | 879.78 Billion KRW | -28.669% |
| Boryung Corporation | 859.62 Billion KRW | -31.686% |
| Bukwang Pharmaceutical Co., Ltd. | 125.92 Billion KRW | -798.927% |
| Ilyang Pharmaceutical Co.,Ltd | 370.53 Billion KRW | -205.503% |
| JW Lifescience Corporation | 206.86 Billion KRW | -447.23% |